How to Reconstitute Ipamorelin: Step-by-Step Reconstitution Guide

What Is Ipamorelin and Why Does Reconstitution Technique Matter?

Ipamorelin is a synthetic pentapeptide ghrelin-receptor agonist that selectively stimulates pituitary growth-hormone release without meaningfully raising cortisol or prolactin at clinical doses. It was characterized in a landmark 1998 paper by Johansen and colleagues, who confirmed its selectivity in rat pituitary cell assays [1]. Unlike older GHRPs such as GHRP-6, ipamorelin produces a clean GH pulse with a favorable safety profile in early human studies [2].

Why Technique Matters for a Peptide

Peptide bonds are fragile. Aggressive mixing, exposure to room temperature, and wrong pH all accelerate denaturation. The US Pharmacopeia (USP) General Chapter <797> Pharmaceutical Compounding of Sterile Preparations sets binding standards for beyond-use dating and sterile technique that directly apply to anyone handling compounded peptide vials [3]. A wrong diluent or a vortex-mixed vial can render the peptide biologically inactive before the first injection.

Ipamorelin's Mechanism in Brief

Ipamorelin binds the GHS-R1a receptor on pituitary somatotrophs, triggering a pulsatile GH release. That pulse peaks roughly 30 to 60 minutes after subcutaneous injection and returns to baseline within two hours, mimicking the body's natural ultradian rhythm. Because the GH pulse is transient, timing your injection correctly, typically 30 minutes before bed or before training, depends on an accurately mixed, accurately dosed preparation.

Supplies You Need Before You Start

Getting the right supplies prevents improvisation at the bench, which is where errors happen. Each item on this list has a clinical reason.

The Essential Supply List

• Ipamorelin vial (compounded, lyophilized, 2 mg or 5 mg)
• Bacteriostatic water for injection (BWI), 30 mL multi-dose vial. BWI contains 0.9% benzyl alcohol as a preservative, which extends the reconstituted peptide's beyond-use date to approximately 28 days when stored at 2 to 8 °C [3].
• Two 29 to 31-gauge, 0.5-inch insulin syringes (one for adding diluent, one for drawing doses)
• Alcohol swabs (70% isopropyl alcohol)
• A clean, hard, flat surface (or a laminar-flow hood if available)
• A permanent marker and label tape to record the date and concentration on the vial
• Refrigerator set to 2 to 8 °C for post-reconstitution storage

Why Not Sterile Water for Injection?

Sterile water for injection (SWFI) carries no preservative. Once you puncture that vial, the beyond-use date of the reconstituted peptide drops to 24 hours per USP <797> [3]. BWI's benzyl alcohol inhibits microbial growth across the 28-day use window, making multi-dose dosing practical. Always confirm your diluent label reads "bacteriostatic water for injection" before proceeding.

Step-by-Step Ipamorelin Reconstitution

Follow these steps in order. Skipping the alcohol-swab step or rushing the mixing step are the two most common errors seen in outpatient peptide programs.

Step 1: Wash Your Hands and Prepare the Work Surface

Wash hands with soap for at least 20 seconds. Dry with a lint-free paper towel. Wipe your work surface with a 70% isopropyl alcohol swab and allow it to air-dry for 30 seconds. This single step reduces particulate and microbial contamination risk substantially [3].

Step 2: Swab Both Vial Tops

Use a fresh alcohol swab on the rubber septum of both the ipamorelin vial and the bacteriostatic water vial. Let both air-dry for 15 seconds. A wet septum can carry alcohol into the vial, which can denature the peptide.

Step 3: Draw Bacteriostatic Water Into the Syringe

The volume of BWI you draw depends on the vial size and the concentration you want. The standard approach for a 2 mg ipamorelin vial is to add 2 mL of BWI, giving a final concentration of 1 mg/mL (1,000 mcg/mL). For a 5 mg vial, adding 5 mL of BWI gives the same 1,000 mcg/mL concentration.

See the dosing calculator section below for alternative concentrations if your prescribed dose requires a different volume.

To draw the BWI: insert the syringe needle through the BWI vial septum, invert the vial, and slowly pull the plunger to draw the needed volume. Withdraw the needle cleanly.

Step 4: Inject BWI Slowly Into the Ipamorelin Vial

Insert the needle into the ipamorelin vial's septum at a 45-degree angle. Direct the stream of BWI toward the inside wall of the vial, not directly onto the lyophilized cake at the bottom. Slow, wall-directed injection prevents foaming and mechanical shear on the peptide. Inject the full BWI volume slowly over 10 to 15 seconds.

Step 5: Gently Swirl, Do Not Shake

Set the vial flat on the counter. Roll it slowly between your palms for 20 to 30 seconds, or swirl it gently in a circular motion. The lyophilized powder should dissolve into a clear, colorless solution. Do not vortex. Do not shake. Shaking introduces air bubbles and mechanical energy that can break peptide bonds [4].

Step 6: Inspect the Solution

Hold the vial up to light. The reconstituted ipamorelin should be:

• Clear (not cloudy or milky)
• Colorless (not yellow or brown)
• Particulate-free (no floating flecks)

If the solution appears cloudy or contains visible particles, discard it. Cloudiness after reconstitution may indicate protein aggregation or contamination.

Step 7: Label the Vial Immediately

Write on the label: the drug name, concentration (e.g., 1,000 mcg/mL), date of reconstitution, and your initials. Per USP <797>, the beyond-use date for a multi-dose vial reconstituted with BWI and stored at 2 to 8 °C is 28 days [3]. Write that expiration date directly on the vial.

Step 8: Refrigerate Promptly

Place the labeled vial in the refrigerator at 2 to 8 °C. Do not freeze a reconstituted vial. Freezing can cause ice-crystal formation that damages peptide structure [4]. Lyophilized (unreconstituted) vials may be stored frozen or refrigerated per manufacturer guidance.

Ipamorelin Dosing Calculator: Converting mcg to Syringe Units

This is where most patients make errors. The key is understanding that a U-100 insulin syringe measures in units, where 100 units equals 1 mL (1,000 microliters).

The Core Formula

Units to draw = (Dose in mcg) / (Concentration in mcg per mL) x 100

Because 1 mL = 100 units on a U-100 syringe, and 1,000 mcg/mL is the standard concentration:

| Prescribed Dose | Concentration | Volume (mL) | Units on U-100 Syringe | |---|---|---|---| | 100 mcg | 1,000 mcg/mL | 0.10 mL | 10 units | | 200 mcg | 1,000 mcg/mL | 0.20 mL | 20 units | | 250 mcg | 1,000 mcg/mL | 0.25 mL | 25 units | | 300 mcg | 1,000 mcg/mL | 0.30 mL | 30 units | | 500 mcg | 1,000 mcg/mL | 0.50 mL | 50 units |

Alternative Concentrations

If your prescriber specified a different volume of BWI, the concentration changes. For example, adding 1 mL of BWI to a 2 mg vial gives 2,000 mcg/mL, so a 300 mcg dose would only require 15 units. Always confirm the concentration before drawing doses.

Why the 0.3 mL Barrel Is Preferred

A 0.3 mL (30-unit) insulin syringe allows finer graduation markings than a 1 mL barrel, reducing measurement error. For doses of 300 mcg or below at the standard 1,000 mcg/mL concentration, a 0.3 mL syringe is the better choice for accuracy.

How to Draw and Inject Ipamorelin: Technique for the Insulin Syringe

Drawing the Dose

1. Remove the refrigerated vial and allow it to reach room temperature for 5 minutes (cold viscous solutions inject with slightly more resistance).
2. Swab the vial septum with a fresh alcohol swab. Allow to air-dry.
3. Insert a fresh 29 to 31-gauge insulin syringe needle through the septum.
4. Invert the vial. Pull the plunger back to the correct unit marking for your dose.
5. Check for air bubbles. Tap the barrel lightly and push small bubbles out before withdrawing.
6. Withdraw the needle from the vial.

Subcutaneous Injection Technique

Ipamorelin is administered subcutaneously, meaning into the fat layer just below the skin. The abdomen (at least 2 inches from the navel) and the outer thigh are the preferred sites.

1. Swab the chosen injection site with 70% isopropyl alcohol. Air-dry for 15 seconds.
2. Pinch a small fold of skin between the thumb and index finger.
3. Insert the needle at a 45-to-90-degree angle depending on subcutaneous fat depth. Use 45 degrees for leaner patients, 90 degrees for those with more adipose tissue.
4. Release the skin pinch once the needle is seated.
5. Depress the plunger steadily over 5 to 10 seconds.
6. Withdraw the needle smoothly and apply gentle pressure with a clean swab. Do not rub.

Rotate injection sites with each dose to prevent lipohypertrophy, the same principle used in insulin therapy for people with diabetes [5].

Needle Gauge and Length Selection

A 31-gauge, 5/16-inch (8 mm) needle is the most commonly prescribed configuration for subcutaneous peptide injections. It produces minimal discomfort and is long enough to clear the dermis in most adults. A 29-gauge needle is acceptable if 31-gauge is unavailable, but larger gauges cause more tissue trauma. Never reuse needles. Reused needles develop barbed tips that increase injection-site pain and introduce infection risk [6].

Ipamorelin Stability: What the Research Tells Us

Lyophilized vs. Reconstituted Stability

Lyophilized peptides are stable for extended periods when stored correctly. A 2020 review of peptide drug stability published in the European Journal of Pharmaceutics and Biopharmaceutics noted that lyophilized formulations retain greater than 95% potency when kept at or below 8 °C and protected from light and moisture [4]. Once reconstituted, the same peptides showed meaningful degradation beyond 28 days at 4 °C.

This is why USP <797> assigns a 28-day beyond-use date for multi-dose vials reconstituted with a preserved diluent like BWI [3]. At room temperature (approximately 25 °C), degradation accelerates markedly, and reconstituted ipamorelin should not remain unrefrigerated for more than 30 minutes before injection.

The Role of Benzyl Alcohol

Benzyl alcohol at 0.9% concentration, the amount in standard BWI, inhibits bacterial and fungal growth across the 28-day use window. The FDA has approved 0.9% benzyl alcohol as a generally recognized as safe (GRAS) preservative in injectable products [7]. For patients with a known benzyl alcohol sensitivity (a rare condition), preservative-free SWFI can be used, but the vial must then be single-use and discarded within 24 hours.

Light and Temperature Degradation

Peptide amide bonds are susceptible to photo-oxidation. Store reconstituted vials in the original cardboard box or an opaque container inside the refrigerator. A 2016 stability study on GH-releasing peptides showed measurable potency loss after 72 hours of exposure to standard fluorescent laboratory lighting at room temperature [8]. The practical takeaway: keep the vial dark and cold between doses.

Clinical Dosing Context: What Prescribers Typically Order

Ipamorelin has no FDA-approved finished drug formulation. It is dispensed as a compounded preparation from a licensed 503A compounding pharmacy or, in research settings, as a research-grade chemical. Prescribers managing growth-hormone deficiency, body composition, or recovery protocols typically order doses in the 200 to 300 mcg range per injection [2].

Typical Protocol Structures

• Nightly dosing: 200 to 300 mcg subcutaneously 30 to 60 minutes before sleep, to align with the natural nocturnal GH pulse.
• Pre-training dosing: 200 to 300 mcg subcutaneously 30 minutes before a workout session.
• Three-times-daily dosing: 100 to 200 mcg in the morning, at midday, and before sleep, used in protocols targeting more sustained IGF-1 elevation.

A 2017 phase II trial (NCT01682577) examining a related GHRP compound in healthy older adults found that GH pulse amplitude correlated linearly with GH secretagogue dose up to 300 mcg, above which the incremental GH response flattened [9]. This informs why most clinical protocols cap individual ipamorelin doses at 300 mcg.

The Ipamorelin-CJC-1295 Combination

Many prescribers combine ipamorelin with CJC-1295 (a GHRH analog) in a single injection. Both peptides are reconstituted separately and drawn into the same syringe at the time of injection. The combination exploits two complementary mechanisms: CJC-1295 extends the GH-releasing signal at the pituitary while ipamorelin amplifies the pulsatile peak. Mixing two peptides in one syringe is acceptable if both are freshly drawn from separately reconstituted, properly stored vials and injected immediately. Do not pre-mix and store the combination; stability data for the combined solution do not currently exist.

Common Reconstitution Errors and How to Avoid Them

Error 1: Adding Too Little or Too Much BWI

Adding 1 mL instead of 2 mL to a 2 mg vial doubles the concentration. If the patient then draws the same number of units, they receive double the intended dose. Measure BWI volume precisely using the syringe graduation marks. Confirm the volume against your prescribed concentration before the first dose.

Error 2: Shaking the Vial

Shaking introduces mechanical shear force and air-water interfacial stress. Both degrade peptide structure. Swirl only.

Error 3: Using an Expired or Contaminated Vial

The 28-day rule exists for a reason. Benzyl alcohol's antimicrobial activity diminishes as the vial is repeatedly punctured and its headspace changes. Discard any vial beyond its beyond-use date, regardless of appearance. A contaminated solution may appear perfectly clear while harboring bacterial endotoxins [3].

Error 4: Injecting Air Bubbles

Small air bubbles (<0.5 mL) in a subcutaneous injection are not medically dangerous the way they are intravenously, but they reduce the accuracy of the dose delivered. Tap the syringe, push bubbles out before withdrawing from the vial.

Error 5: Skipping Site Rotation

Injecting into the same site repeatedly causes lipohypertrophy, a local fat-tissue thickening. Lipohypertrophy alters absorption kinetics and reduces dose reliability, a well-documented problem in insulin-dependent diabetes that applies equally to peptide injections [5].

Safety, Contraindications, and When to Contact Your Prescriber

Ipamorelin is generally well-tolerated in clinical studies. The most common adverse effects at doses up to 300 mcg include mild transient flushing, a brief sensation of warmth after injection, and occasional injection-site erythema [2]. These typically resolve within 30 minutes.

Conditions That Require Prescriber Clearance Before Use

• Active malignancy (GH secretagogues theoretically stimulate IGF-1, which is mitogenic)
• Pregnancy or breastfeeding
• Known hypersensitivity to benzyl alcohol
• Acromegaly or pituitary adenoma
• Age <18 years (safety data are insufficient)

The Endocrine Society's 2019 Clinical Practice Guideline on growth hormone deficiency in adults notes that GH-stimulating therapies are contraindicated in active malignancy and should be used with caution in patients with diabetes due to GH-mediated insulin resistance [10]. The same caution extends to GH secretagogues like ipamorelin.

Signs of Improper Reconstitution to Report

Contact your prescriber or pharmacy if the reconstituted solution is cloudy, colored, or contains visible particles, if the injection site develops persistent redness, swelling, or warmth beyond 24 hours, or if you experience systemic symptoms such as fever after injection. These may indicate contamination or an incorrect preparation.

Storing Your Reconstituted Ipamorelin Vial

• Refrigerate at 2 to 8 °C immediately after reconstitution.
• Do not freeze the reconstituted vial.
• Keep the vial in its original box or wrapped in foil to protect from light.
• Use within 28 days of the reconstitution date.
• Allow the vial to reach room temperature (5 minutes on the counter) before each use to reduce injection resistance.
• Swab the septum with a fresh alcohol swab each time you puncture the vial.

Per USP <797>, a compounded sterile preparation assigned a Category 2 classification should not exceed the 28-day beyond-use date for multi-dose preparations [3]. Your compounding pharmacy will print this date on the label; do not override it.